Katz Family Division of Nephrology and Hypertension/Peggy and Harold Katz Family Drug Discovery Center, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.
J Am Soc Nephrol. 2021 Jan;32(1):9-31. doi: 10.1681/ASN.2020050697. Epub 2020 Dec 18.
In the past few decades, sphingolipids and sphingolipid metabolites have gained attention because of their essential role in the pathogenesis and progression of kidney diseases. Studies in models of experimental and clinical nephropathies have described accumulation of sphingolipids and sphingolipid metabolites, and it has become clear that the intracellular sphingolipid composition of renal cells is an important determinant of renal function. Proper function of the glomerular filtration barrier depends heavily on the integrity of lipid rafts, which include sphingolipids as key components. In addition to contributing to the structural integrity of membranes, sphingolipid metabolites, such as sphingosine-1-phosphate (S1P), play important roles as second messengers regulating biologic processes, such as cell growth, differentiation, migration, and apoptosis. This review will focus on the role of S1P in renal cells and how aberrant extracellular and intracellular S1P signaling contributes to the pathogenesis and progression of kidney diseases.
在过去的几十年中,由于鞘脂及其代谢物在肾脏疾病的发病机制和进展中的重要作用,它们受到了关注。实验性和临床肾脏病模型的研究描述了鞘脂及其代谢物的积累,并且已经清楚的是,肾脏细胞的细胞内鞘脂组成是肾功能的重要决定因素。肾小球滤过屏障的正常功能在很大程度上取决于脂筏的完整性,而脂筏中鞘脂是关键成分。鞘脂代谢物,如鞘氨醇-1-磷酸(S1P),除了有助于膜的结构完整性外,还作为第二信使发挥重要作用,调节细胞生长、分化、迁移和凋亡等生物学过程。这篇综述将重点介绍 S1P 在肾脏细胞中的作用,以及细胞外和细胞内 S1P 信号传导异常如何导致肾脏疾病的发病机制和进展。